AstraZeneca News

AstraZeneca | F-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 19 16:38 ET

AstraZeneca | 8-A12B: Registration of a class of securities on a national securities exchange

Mar 5 16:47 ET

AstraZeneca | 424B2: Prospectus

Feb 23 16:17 ET

AstraZeneca | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 22 15:31 ET

AstraZeneca | 424B2: Prospectus

Feb 21 08:15 ET

AstraZeneca | 144: Notice of Proposed Sale of Securities

Nov 13, 2023 08:19 ET

AstraZeneca | 8-A12B: Registration of a class of securities on a national securities exchange

Mar 13, 2023 16:37 ET

AstraZeneca | 424B2: Prospectus

Mar 2, 2023 16:54 ET

AstraZeneca | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 28, 2023 20:52 ET

AstraZeneca | 424B2: Prospectus

Feb 28, 2023 10:18 ET

AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 14, 2021 12:12 ET

AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 14, 2021 11:01 ET

AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 6, 2021 14:11 ET

AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 6, 2021 11:13 ET

AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 30, 2021 16:23 ET

AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 4, 2021 16:44 ET

AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 4, 2021 14:59 ET

AstraZeneca | 8-A12B: Registration of a class of securities on a national securities exchange

Jun 1, 2021 16:15 ET

AstraZeneca | 424B2: Prospectus

May 27, 2021 17:28 ET

AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 27, 2021 14:05 ET